Immunocore Holdings Plc
IMCR
Revenue
75.40M
▲4.90M▲6.95%
3 Months ChangeAssets
301.77M
▲104.58M▲53.03%
12 Months ChangeLiabilities
130.23M
▼-11.62M▼-8.19%
12 Months ChangeFree Cash Flow
-5.02M
▼-12.56M▼-166.56%
12 Months ChangeRevenue/Cost Of Revenue
Revenue
Cost Of Revenue
Loading...
| Date | Revenue | Cost Of Revenue |
|---|---|---|
Net Profit/Loss
Net Profit/Loss
Baseline
Loading...
| Date | Net Profit/Loss |
|---|---|
Assets/Liabilities
Assets
Liabilities
Loading...
| Date | Assets | Liabilities |
|---|---|---|
Cash Flows
Operating (Cash Flow)
Investing (Cash Flow)
Financing (Cash Flow)
Free Cash Flow
Loading...
| Date | Operating (Cash Flow) | Investing (Cash Flow) | Financing (Cash Flow) | Free Cash Flow |
|---|---|---|---|---|
EPS
EPS (Diluted)
Loading...
| Date | EPS | EPS (Diluted) |
|---|---|---|
Outstanding Shares
Loading...
| Date | Outstanding Shares |
|---|---|
Recent 8-K/10-Q Filings
2024-09-16
Form 8-K
ID: 0001140361-24-041100
2024-08-29
Form 8-K
ID: 0001140361-24-039083
2024-08-08
Form 8-K
ID: 0001140361-24-036283
2024-08-08
Form 10-Q
ID: 0001671927-24-000005
2024-05-31
Form 8-K
ID: 0001140361-24-028366
2024-05-30
Form 8-K
ID: 0001140361-24-028194
2024-05-28
Form 8-K
ID: 0001140361-24-027667
2024-05-23
Form 8-K
ID: 0001140361-24-027312
2024-05-08
Form 8-K
ID: 0001140361-24-024789
2024-05-08
Form 10-Q
ID: 0001140361-24-024784